MedStar Lands Colorectal Surgery Pioneer, Signaling Regional Healthcare Shift

Washington, D.C. – November 8, 2025 – MedStar Health has made a strategic move to bolster its colorectal surgery program with the appointment of internationally renowned surgeon Dr. Steven Wexner as Physician Executive Director and System Chief of Colorectal Surgery. The move positions MedStar to further compete with regional powerhouses like Johns Hopkins and the University of Maryland Medical Center, while promising an elevated standard of care for patients across the Maryland and Washington, D.C. region.

Dr. Wexner, formerly of Cleveland Clinic Florida, brings over 38 years of experience and a legacy of innovation to MedStar Georgetown University Hospital. He is widely recognized as a pioneer in minimally invasive colorectal surgery and for his dedication to optimizing patient outcomes, particularly in complex cases like rectal cancer and inflammatory bowel disease. Notably, Dr. Wexner is the most cited living colorectal surgeon, boasting over 1,200 publications and 43,000 citations – a testament to his profound impact on the field.

Beyond the Scalpel: A Legacy of Innovation & Training

Dr. Wexner’s influence extends far beyond the operating room. He is credited with developing the Wexner Incontinence and Constipation Scores – clinical assessment tools now widely used by surgeons worldwide to evaluate and manage patient symptoms. These scores have become essential components of patient care and research, facilitating standardized assessment and improved clinical outcomes.

“His impact on the field is truly remarkable,” said an anonymous source familiar with Dr. Wexner’s work. “He’s not just a brilliant surgeon, but a true innovator who is always pushing the boundaries of what’s possible.”

Beyond his clinical work, Dr. Wexner has dedicated his career to educating the next generation of surgeons, having trained over 800 surgeons globally. This commitment to mentorship underscores his belief in fostering continuous improvement and advancing surgical knowledge. His approach is to empower his trainees to become independent and innovative surgeons.

MedStar’s Strategic Play in a Competitive Market

The appointment of Dr. Wexner is widely seen as a strategic move by MedStar Health to strengthen its position in the highly competitive Mid-Atlantic healthcare market. While MedStar Georgetown University Hospital is a respected institution, it currently lacks a specific national ranking for colorectal surgery, unlike its rivals Johns Hopkins and the University of Maryland Medical Center.

“This appointment is a clear signal that MedStar is serious about becoming a regional leader in colorectal care,” stated an anonymous healthcare administrator. “Dr. Wexner’s expertise and reputation will undoubtedly attract patients and enhance the hospital’s overall profile.”

Bringing in a surgeon of Dr. Wexner’s caliber isn’t simply about attracting patients. It’s about attracting talent, enhancing research capabilities, and potentially driving innovation within the hospital system. MedStar is hoping that Dr. Wexner’s presence will serve as a catalyst for further investment in colorectal surgery and related fields.

Focus on Minimally Invasive Techniques and Patient-Centered Care

Dr. Wexner is a staunch advocate for minimally invasive surgical techniques, including laparoscopic and robotic-assisted procedures. These techniques offer several benefits to patients, including smaller incisions, reduced pain, faster recovery times, and lower complication rates. He is known for his expertise in complex cases, particularly those requiring re-operative surgery.

“He’s a master of his craft,” said an anonymous colleague. “He’s able to tackle even the most challenging cases with precision and skill.”

His focus extends beyond technical proficiency. Dr. Wexner is a firm believer in patient-centered care, emphasizing the importance of individualized treatment plans and open communication. He believes that patients should be actively involved in their care and empowered to make informed decisions.

Looking Ahead: Potential for Growth and Innovation

The arrival of Dr. Wexner at MedStar Health is expected to have a ripple effect throughout the hospital system and the region. While MedStar already boasts a strong foundation in colorectal care, Dr. Wexner’s expertise promises to elevate the standard of care even further.

“This is a game-changer for MedStar,” said an anonymous industry analyst. “Dr. Wexner’s presence will undoubtedly attract top talent and drive innovation in colorectal surgery.”

Industry observers anticipate that MedStar will capitalize on Dr. Wexner’s expertise to expand its colorectal surgery program, invest in new technologies, and conduct groundbreaking research. The hospital system is also likely to enhance its outreach efforts to attract patients from across the region and beyond. The focus will be on providing comprehensive, patient-centered care that addresses the unique needs of each individual.

Dr. Wexner’s appointment is more than just the addition of a skilled surgeon. It’s a strategic investment in the future of colorectal care and a signal that MedStar Health is committed to becoming a regional leader in innovation and patient care.